Form 4: Envista Holdings Director Vivek Jain Receives Annual Equity Grant of 10,450 Restricted Stock Units

Envista Holdings Corp. Director Vivek Jain was granted 10,450 Restricted Stock Units (RSUs) as part of his annual equity compensation, vesting on the first anniversary of the grant date.

Summary

• Vivek Jain, a Director of Envista Holdings Corp. (NVST), acquired 10,450 shares of common stock on June 10, 2025.
• This acquisition was an annual equity grant of Restricted Stock Units (RSUs) for his service as a director.
• The RSUs were granted at a price of $0 per share, indicating they are compensation rather than a purchase.
• These RSUs will vest on the first anniversary of the grant date and are convertible into common stock on a one-to-one basis.
• Following this transaction, Vivek Jain beneficially owns 43,615 shares of Envista Holdings Corp. common stock directly.

Sentiment

Score: 7

Explanation: The filing reports a standard, expected equity grant to a director, which is generally a positive sign of alignment between management and shareholder interests, without any negative implications or surprises.

Positives

• The grant of 10,450 Restricted Stock Units (RSUs) to Director Vivek Jain aligns his interests with long-term shareholder value, as the RSUs vest over time.
• Equity compensation is a common and effective practice for retaining and incentivizing key board members, promoting stability and commitment.

Negatives

• No direct negatives are apparent from this specific Form 4 filing, as it reports a standard and expected insider equity grant.

Risks

• No specific risks are mentioned or implied within this Form 4 filing, which primarily reports an insider transaction related to compensation.

Future Outlook

The Restricted Stock Units granted to Director Vivek Jain are scheduled to vest on the first anniversary of the grant date (June 10, 2025), indicating a future conversion to common stock around June 10, 2026.

Management Comments

• The filing explicitly states that the transaction consists of an annual equity grant of Restricted Stock Units for the Reporting Person's service as a director of the Issuer.

Industry Context

Equity grants to directors are a common practice across various industries, including the healthcare and dental products sector where Envista Holdings operates. This practice serves to align director incentives with long-term company performance and shareholder interests, reflecting standard corporate governance practices.

Comparison to Industry Standards

• The practice of granting Restricted Stock Units (RSUs) as part of director compensation is a standard industry practice across publicly traded companies, including those in the medical device and dental industries such as Dentsply Sirona (XRAY) or Align Technology (ALGN), to incentivize long-term commitment and performance.
• The grant price of $0 for RSUs is typical for equity compensation, as these are awarded as part of a compensation package rather than purchased.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns their interests with long-term shareholder value, as the director's compensation is tied to the company's stock performance, potentially fostering better governance and strategic decisions.
• Employees: No direct impact on general employees is indicated by this specific filing, as it pertains to director compensation.

Next Steps

• The 10,450 Restricted Stock Units (RSUs) granted to Director Vivek Jain are expected to vest on the first anniversary of the grant date (approximately June 10, 2026).
• Upon vesting, these RSUs will convert into shares of Envista Holdings Corp. common stock on a one-to-one basis, increasing Vivek Jain's direct beneficial ownership.

Key Dates

Recommendation

Keywords

Envista Holdings Corp, NVST, Form 4, Insider Transaction, Restricted Stock Units, RSUs, Equity Grant, Director Compensation, Beneficial Ownership